Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's Imlygic May Not Boost Earnings But It Will Change Cancer Care
Amgen's Imlygic May Not Boost Earnings But It Will Change Cancer Care
Amgen's Imlygic May Not Boost Earnings But It Will Change Cancer Care
Submitted by
admin
on October 28, 2015 - 9:17am
Source:
Forbes
News Tags:
Amgen
Imlygic
T-Vec
blood cancer
Headline:
Amgen's Imlygic May Not Boost Earnings But It Will Change Cancer Care
Do Not Allow Advertisers to Use My Personal information
